Literature DB >> 10891362

Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.

O M El-Agnaf1, D S Mahil, B P Patel, B M Austen.   

Abstract

beta-Amyloid protein (Abeta) is the major component of senile plaques found in the brains of Alzheimer's patients. A novel ELISA has been developed which probes the early stages of oligomerization of Abeta. Incubation of Abeta solutions at 37 degrees C and pH 7.4 produces soluble oligomers in a concentration-dependent manner. Fresh Abeta42 solutions rapidly form soluble oligomers, whereas Abeta40 solutions require prolonged incubation to produce oligomers. Fresh Abeta42 solutions are more toxic to human neuroblastoma SH-SY5Y cells than Abeta40 solutions, possibly mediated by soluble oligomers. The differences between Abeta42 and Abeta40 could explain the association of the longer form with familial early-onset Alzheimer's disease. We also report a new strategy for solid-phase synthesis of Abeta peptides which gives high yield and purity of the initial crude preparation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891362     DOI: 10.1006/bbrc.2000.3051

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

2.  Discovery and characterization of a mammalian amyloid disaggregation activity.

Authors:  Amber N Murray; James P Solomon; Ya-Juan Wang; William E Balch; Jeffery W Kelly
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

3.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody.

Authors:  Ning Xia; Lin Liu; Michael G Harrington; Jianxiu Wang; Feimeng Zhou
Journal:  Anal Chem       Date:  2010-11-12       Impact factor: 6.986

4.  Probing the mechanism of inhibition of amyloid-β(1-42)-induced neurotoxicity by the chaperonin GroEL.

Authors:  Marielle A Wälti; Joseph Steiner; Fanjie Meng; Hoi Sung Chung; John M Louis; Rodolfo Ghirlando; Vitali Tugarinov; Avindra Nath; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

5.  In silico study of amyloid beta-protein folding and oligomerization.

Authors:  B Urbanc; L Cruz; S Yun; S V Buldyrev; G Bitan; D B Teplow; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

6.  Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation.

Authors:  Nasrollah Rezaei-Ghaleh; Karin Giller; Stefan Becker; Markus Zweckstetter
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

7.  Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.

Authors:  Ali Reza A Ladiwala; Mauricio Mora-Pale; Jason C Lin; Shyam Sundhar Bale; Zachary S Fishman; Jonathan S Dordick; Peter M Tessier
Journal:  Chembiochem       Date:  2011-06-10       Impact factor: 3.164

8.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

Review 9.  Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.

Authors:  Dena A M Amer; G Brent Irvine; Omar M A El-Agnaf
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

10.  Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.

Authors:  Bonnie J Berry; Alec S T Smith; Christopher J Long; Candace C Martin; James J Hickman
Journal:  ACS Chem Neurosci       Date:  2018-05-22       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.